Combined Use of the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as a Prognostic Predictor in Patients with Operable Soft Tissue Sarcoma.
about
Combined Use of the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as a Prognostic Predictor in Patients with Operable Soft Tissue Sarcoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Combined Use of the Neutrophil ...... Operable Soft Tissue Sarcoma.
@en
Combined Use of the Neutrophil ...... Operable Soft Tissue Sarcoma.
@nl
type
label
Combined Use of the Neutrophil ...... Operable Soft Tissue Sarcoma.
@en
Combined Use of the Neutrophil ...... Operable Soft Tissue Sarcoma.
@nl
prefLabel
Combined Use of the Neutrophil ...... Operable Soft Tissue Sarcoma.
@en
Combined Use of the Neutrophil ...... Operable Soft Tissue Sarcoma.
@nl
P2093
P2860
P356
P1433
P1476
Combined Use of the Neutrophil ...... h Operable Soft Tissue Sarcoma
@en
P2093
Jingjing Li
Xing Zhang
Yuanxiang Guan
Zhiwei Zhou
P2860
P304
P356
10.7150/JCA.24871
P577
2018-05-25T00:00:00Z